CG Oncology Inc.
Isabel Kalofonos (Chief Commercial Officer) reports CGON insider transactions
About this filing
CG Oncology Inc. (CGON) filed Form 4 (insider transaction) with the SEC on Oct 19, 2026. Form 4 reports a company insider’s trades in the company’s shares.
Key facts
- Insider
- Isabel Kalofonos · Chief Commercial Officer
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Oct 15, 2026 | A · grantEmployee Stock Option (right to buy)Footnotes F1 | +92,000 | $0.00 | $0.00 | 92,000 | Direct |
Footnotes
- F1 The stock option vests over a four-year period starting on October 13, 2026 (the "Vesting Commencement Date"), with 25% of the shares vesting on the date that is twelve months after the Vesting Commencement Date and the remainder vesting in thirty-six equal monthly installments over the subsequent three-year period, subject to the Reporting Person's continuous service to the Issuer through each vesting date.
More CGON filings
- 4
Filed Nov 17, 2026
- 8-K
Filed Nov 16, 2026
- 10-Q
Filed Nov 6, 2026
- 8-K
Filed Nov 6, 2026
- 4
Filed Oct 19, 2026
- 3
Filed Oct 19, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.